| Product Code: ETC7656555 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Multiple System Atrophy (MSA) Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Multiple System Atrophy (MSA) Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Multiple System Atrophy (MSA) Market - Industry Life Cycle |
3.4 Israel Multiple System Atrophy (MSA) Market - Porter's Five Forces |
3.5 Israel Multiple System Atrophy (MSA) Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Multiple System Atrophy (MSA) Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
4 Israel Multiple System Atrophy (MSA) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis rates of multiple system atrophy (MSA) in Israel |
4.2.2 Technological advancements in diagnostic tools and treatment options for MSA |
4.2.3 Growing research and development efforts focused on finding effective therapies for MSA |
4.3 Market Restraints |
4.3.1 Limited treatment options currently available for MSA in Israel |
4.3.2 High costs associated with MSA treatment and management |
4.3.3 Lack of healthcare infrastructure specialized in managing MSA patients in Israel |
5 Israel Multiple System Atrophy (MSA) Market Trends |
6 Israel Multiple System Atrophy (MSA) Market, By Types |
6.1 Israel Multiple System Atrophy (MSA) Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Multiple System Atrophy (MSA) Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Israel Multiple System Atrophy (MSA) Market Revenues & Volume, By Parkinsonian, 2021- 2031F |
6.1.4 Israel Multiple System Atrophy (MSA) Market Revenues & Volume, By Cerebellar, 2021- 2031F |
6.2 Israel Multiple System Atrophy (MSA) Market, By Diagnosis |
6.2.1 Overview and Analysis |
6.2.2 Israel Multiple System Atrophy (MSA) Market Revenues & Volume, By Magnetic Resonance Imaging (MRI), 2021- 2031F |
6.2.3 Israel Multiple System Atrophy (MSA) Market Revenues & Volume, By Positron Emission Tomography (PET), 2021- 2031F |
6.2.4 Israel Multiple System Atrophy (MSA) Market Revenues & Volume, By Single Photon Emission Computed Tomography (SPECT), 2021- 2031F |
6.2.5 Israel Multiple System Atrophy (MSA) Market Revenues & Volume, By Tilt Table Test, 2021- 2031F |
6.2.6 Israel Multiple System Atrophy (MSA) Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Multiple System Atrophy (MSA) Market Import-Export Trade Statistics |
7.1 Israel Multiple System Atrophy (MSA) Market Export to Major Countries |
7.2 Israel Multiple System Atrophy (MSA) Market Imports from Major Countries |
8 Israel Multiple System Atrophy (MSA) Market Key Performance Indicators |
8.1 Average time from symptom onset to diagnosis for MSA patients in Israel |
8.2 Number of clinical trials and research studies focusing on MSA treatment in Israel |
8.3 Patient satisfaction rates with MSA care and support services in Israel |
9 Israel Multiple System Atrophy (MSA) Market - Opportunity Assessment |
9.1 Israel Multiple System Atrophy (MSA) Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Multiple System Atrophy (MSA) Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
10 Israel Multiple System Atrophy (MSA) Market - Competitive Landscape |
10.1 Israel Multiple System Atrophy (MSA) Market Revenue Share, By Companies, 2024 |
10.2 Israel Multiple System Atrophy (MSA) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here